Artículos por temáticas

Gabapentin for pain, movement disorders, and irritability in neonates and infants

Burnsed JC, Heinan K, Letzkus L, Zanelli S.

Dev Med Child Neurol. 2020 Mar;62(3):386-389. doi: 10.1111/dmcn.14324. Epub 2019 Jul 25.

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.

Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10. Review.

Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.

Wong LC, Wu YT, Hsu CJ, Weng WC, Tsai WC, Lee WT.

Front Neurol. 2019 Jun 28;10:641. doi: 10.3389/fneur.2019.00641. eCollection 2019.

Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders.

Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL.

Stereotact Funct Neurosurg. 2019;97(2):113-119. doi: 10.1159/000500993. Epub 2019 Jul 9.

Antisense therapies for movement disorders.

Scoles DR, Pulst SM.

Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8. Review.

Recent developments in drug-induced movement disorders: a mixed picture.

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.

Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.

Reliability in Mandibular Movement Evaluation Using Photogrammetry in Patients With Temporomandibular Disorders.

Andrade RM, Guimarães LR, Ribeiro AP, Pasqual Marques A, Crivello O Jr, Gonçalves de Carvalho BK, Amado João SM.

J Manipulative Physiol Ther. 2019 May;42(4):267-275. doi: 10.1016/j.jmpt.2018.11.008. Epub 2019 Jun 29.

Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Peralta C, Biafore F, Depetris TS, Bastianello M.

Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3. Review.

Editorial: Update on movement disorders.

Svenningsson P, Frucht SJ.

Curr Opin Neurol. 2019 Aug;32(4):564-565. doi: 10.1097/WCO.0000000000000709. No abstract available.

A dyadic group-movement therapy with adolescent girls with eating disorders.

Dor-Haim M, Yaroslavsy A, Lev Azolay T, Dascal T, Toledano A, Latzer Y, Stein D.

J Clin Psychol. 2019 Aug;75(8):1429-1443. doi: 10.1002/jclp.22785. Epub 2019 Jun 26.

Gene-targeting approaches for movement disorders: recent advances.

Kaplitt MG.

Curr Opin Neurol. 2019 Aug;32(4):566-570. doi: 10.1097/WCO.0000000000000719.

Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.

Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.

J Clin Psychopharmacol. 2019 Jul/Aug;39(4):336-343. doi: 10.1097/JCP.0000000000001061.

A comparative study on oral health status in Greek preschool children with neurodevelopmental disorders with movement limitations.

Tzouanaki A, Agouropoulos A, Kavvadia K, Papagiannoulis L.

Spec Care Dentist. 2019 Jul;39(4):421-428. doi: 10.1111/scd.12390. Epub 2019 May 27.

Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.

Bohlega SA, Abou-Al-Shaar H, AlDakheel A, Alajlan H, Bohlega BS, Meyer BF, Monies D, Cupler EJ, Al-Saif AM.

Parkinsonism Relat Disord. 2019 Jul;64:145-149. doi: 10.1016/j.parkreldis.2019.02.039. Epub 2019 Feb 28.

Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration.

González-Casacuberta I, Juárez-Flores DL, Morén C, Garrabou G.

Front Neurosci. 2019 Sep 10;13:894. doi: 10.3389/fnins.2019.00894. eCollection 2019. Review.